Vitamin B12 / BrainVol Cancer Research Results

VitB12, Vitamin B12: Click to Expand ⟱
Features:

Vitamin B12 = cobalamin (water-soluble vitamin; forms: methylcobalamin, adenosylcobalamin, cyanocobalamin, hydroxocobalamin). Sources: animal-derived foods; requires intrinsic factor–mediated absorption; transport via transcobalamin (TCII). Primary mechanisms (ranked):
1) Methionine synthase cofactor → homocysteine → methionine → SAM → DNA/RNA/histone methylation (one-carbon metabolism integration).
2) Methylmalonyl-CoA mutase cofactor → odd-chain FA / branched-chain AA metabolism; mitochondrial anaplerosis support.
3) Genome stability support (via nucleotide synthesis + methylation balance).
Bioavailability/PK relevance: Active absorption saturable (~1–2 µg/meal via IF); passive diffusion at high oral doses (~1%); serum levels tightly regulated; intracellular utilization depends on TCII uptake and lysosomal processing.
In-vitro vs oral exposure: Most cancer cell studies use supraphysiologic cobalamin or manipulate one-carbon flux; effects typically reflect methylation / nucleotide synthesis dependency rather than direct cytotoxicity.
Clinical evidence status: Essential nutrient; deficiency correction clearly beneficial; no established anticancer efficacy; epidemiology mixed (very high serum B12 sometimes correlates with cancer presence—likely reverse causality/biomarker phenomenon rather than causation).

Helps make red blood cells, metabolize food and prevent nerve damage.

Vitamin B12 (Cobalamin) — Cancer vs Normal Pathway Effects

Rank Pathway / Axis Cancer Cells (↑ / ↓ / ↔) Normal Cells (↑ / ↓ / ↔) TSF Primary Effect Notes / Interpretation
1 One-carbon metabolism (Methionine synthase → SAM) ↑ methylation capacity; ↑ nucleotide synthesis (proliferation support) ↑ genome stability; ↑ normal DNA synthesis R→G Methyl donor cycling Supports SAM production; in rapidly dividing tumors may facilitate growth if not limiting.
2 DNA methylation / Epigenetics ↔ / ↑ (context-dependent; can restore normal methylation if deficient) ↑ methylation homeostasis G Epigenetic stability Deficiency → hypomethylation/genomic instability; supplementation restores baseline rather than inducing supraphysiologic hypermethylation in most settings.
3 Nucleotide synthesis (via folate cycle coupling) ↑ proliferation support (if B12 limiting) ↑ normal hematopoiesis R→G DNA replication capacity Mechanistically linked to folate; deficiency leads to megaloblastic anemia.
4 Mitochondrial metabolism (Methylmalonyl-CoA mutase) ↔ (supports baseline metabolism) ↑ mitochondrial function R Anaplerotic support Prevents methylmalonic acid accumulation; preserves mitochondrial efficiency.
5 ROS ↔ (indirect) ↓ oxidative stress (deficiency correction) R Redox balance (secondary) Effects mediated through improved mitochondrial and methylation balance.
6 NRF2 ↔ (no direct axis) ↔ G Adaptive response (indirect) No primary NRF2-targeting activity established.
7 Ca2+ ↔ ↔ P Not a core pathway No meaningful Ca²⁺ modulation axis.
8 HIF-1α / Warburg ↔ (indirect via proliferation capacity) ↔ G Metabolic permissiveness No direct hypoxia pathway targeting; effects are permissive rather than suppressive.
9 Ferroptosis ↔ ↔ R Not established No defined ferroptotic mechanism.
10 Clinical Translation Constraint Essential nutrient; correction of deficiency critical. No validated anticancer benefit; very high serum B12 often reflects disease state rather than supplementation causality. — Evidence Interpret epidemiologic associations cautiously (reverse causation common).

TSF legend: P: 0–30 min | R: 30 min–3 hr | G: >3 hr
BrainVol, Hippocampal Volume: Click to Expand ⟱
Source:
Type:
Brain volume is a key biomarker in Alzheimer’s disease (AD) and is closely associated with the progression of the disease
-AD is characterized by progressive brain shrinkage (atrophy)
-Hippocampus: One of the earliest and most affected areas; crucial for memory formation.
-Medial Temporal Lobe: Including the entorhinal cortex; important in converting short-term to long-term memory.
-Parietal and Frontal Lobes: Atrophy spreads here as the disease progresses, affecting language, spatial awareness, and executive function.
-MRI imaging is widely used to measure brain volume loss.
-Rate of volume loss can predict cognitive decline and transition from:
-Normal aging → Mild Cognitive Impairment (MCI) → Alzheimer’s Disease.

Rate of Brain Volume Loss
  Population Group	Estimated Brain Volume Loss / Year
  Healthy aging adults	~0.2–0.5%
  MCI patients	        ~1–2%
  AD patients	        ~2–3% or more


Scientific Papers found: Click to Expand⟱
6961- FA,  VitB12,  VitB6,  Silicon,  Alum  B Vitamins Prevent Iron-Associated Brain Atrophy and Domain-Specific Effects of Iron, Copper, Aluminum, and Silicon on Cognition in Mild Cognitive Impairment
- Trial, AD, NA
*BrainVol↝, *cognitive↝, *cognitive↑, *Dose↝, *other↝, *Hcy/homoC↓, *Risk↓, *BrainVol∅, *BrainVol↑, *other↝, *cognitive↑, *cognitive↑, *other↝, *Risk↝,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Transcription & Epigenetics(tgid=7) ⓘ

other↝, 3,  

Synaptic & Neurotransmission(tgid=18) ⓘ

BrainVol↑, 1,   BrainVol↝, 1,   BrainVol∅, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

Dose↝, 1,  

Clinical Biomarkers(tgid=22) ⓘ

Hcy/homoC↓, 1,  

Functional Outcomes(tgid=23) ⓘ

cognitive↑, 3,   cognitive↝, 1,   Risk↓, 1,   Risk↝, 1,  
Total Targets: 10

Scientific Paper Hit Count for: BrainVol, Hippocampal Volume
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:165  Target#:1372  State#:%  Dir#:4
  wNotes=0  sortOrder:rid,rpid

 

Home Page